10-123051189-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001609.4(ACADSB):​c.1128+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000024 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00027 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ACADSB
NM_001609.4 splice_region, intron

Scores

2
Splicing: ADA: 0.9483
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.38

Publications

1 publications found
Variant links:
Genes affected
ACADSB (HGNC:91): (acyl-CoA dehydrogenase short/branched chain) Short/branched chain acyl-CoA dehydrogenase(ACADSB) is a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. Substrate specificity is the primary characteristic used to define members of this gene family. The ACADSB gene product has the greatest activity towards the short branched chain acyl-CoA derivative, (S)-2-methylbutyryl-CoA, but also reacts significantly with other 2-methyl branched chain substrates and with short straight chain acyl-CoAs. The cDNA encodes for a mitochondrial precursor protein which is cleaved upon mitochondrial import and predicted to yield a mature peptide of approximately 43.7-KDa. [provided by RefSeq, Jul 2008]
ACADSB Gene-Disease associations (from GenCC):
  • 2-methylbutyryl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACADSBNM_001609.4 linkc.1128+3A>G splice_region_variant, intron_variant Intron 9 of 10 ENST00000358776.7 NP_001600.1 P45954-1A0A0S2Z3P9
ACADSBNM_001330174.3 linkc.822+3A>G splice_region_variant, intron_variant Intron 8 of 9 NP_001317103.1 P45954-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACADSBENST00000358776.7 linkc.1128+3A>G splice_region_variant, intron_variant Intron 9 of 10 1 NM_001609.4 ENSP00000357873.3 P45954-1
ACADSBENST00000368869.8 linkc.822+3A>G splice_region_variant, intron_variant Intron 8 of 9 2 ENSP00000357862.4 P45954-2

Frequencies

GnomAD3 genomes
AF:
0.0000242
AC:
1
AN:
41316
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000519
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000249
AC:
6
AN:
24094
AF XY:
0.000146
show subpopulations
Gnomad AFR exome
AF:
0.000776
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000531
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000265
AC:
9
AN:
33912
Hom.:
0
Cov.:
0
AF XY:
0.000333
AC XY:
6
AN XY:
18006
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
736
American (AMR)
AF:
0.00
AC:
0
AN:
824
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
296
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1456
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
78
European-Non Finnish (NFE)
AF:
0.000385
AC:
9
AN:
23384
Other (OTH)
AF:
0.00
AC:
0
AN:
1194
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000057), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000242
AC:
1
AN:
41316
Hom.:
0
Cov.:
0
AF XY:
0.0000521
AC XY:
1
AN XY:
19186
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
10488
American (AMR)
AF:
0.00
AC:
0
AN:
3826
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
930
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1500
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
96
European-Non Finnish (NFE)
AF:
0.0000519
AC:
1
AN:
19276
Other (OTH)
AF:
0.00
AC:
0
AN:
570
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain:2
Apr 01, 2020
Elsea Laboratory, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
23
DANN
Benign
0.79
PhyloP100
2.4

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.95
dbscSNV1_RF
Benign
0.62
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760423996; hg19: chr10-124810705; API